3-(3-Chloropropanoyl)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)urea

Catalog No. :
ACTRCS951
CAS No. :
1000930-40-4
Molecular Formula :
C12H13ClN2O4
Molecular Weight :
284.70

IUPAC Name:3-chloro-N-((2,3-dihydrobenzo[b][1,4]dioxin-6-yl)carbamoyl)propanamide

3-(3-Chloropropanoyl)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)urea structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$100.00Login to see priceInquiryInquiry
100mg95%$141.00Login to see priceInquiryInquiry
250mg95%$194.00Login to see priceInquiryInquiry
1g95%$479.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(3-Chloropropanoyl)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)urea
IUPAC Name3-chloro-N-((2,3-dihydrobenzo[b][1,4]dioxin-6-yl)carbamoyl)propanamide
MDL No.MFCD09863266
Molecular FormulaC12H13ClN2O4
Molecular Weight284.70
SMILESO=C(NC(CCCl)=O)NC1=CC=C(OCCO2)C2=C1
InChI KeySSBHNJHDGJPWBY-UHFFFAOYSA-N
Synonym3-(3-Chloropropanoyl)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)urea;Propanamide, 3-chloro-N-[[(2,3-dihydro-1,4-benzodioxin-6-yl)amino]carbonyl]-
CAS No.1000930-40-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACTRCS951 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTRCS951 route product structure diagram
    ACTRCS9511000930-40-4
Inquiry

2. ACTRCS951 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTRCS951 route product structure diagram
    ACTRCS9511000930-40-4
Inquiry

Comments (0)